North America Pharmaceutical Deal Trends Led in Terms of Region, Followed by Europe and Asia-Pacific.

Hyderabad, March 18, 2016 (Newswire.com) - Summary: 

MIR Research’s latest report, "Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity" discusses deal-making trends for a range of deal types, such as Mergers & Acquisitions (M&A) and strategic alliances. It also examines preference by deal type, along with disclosed deal values from 2010 to July 2015, covering start-ups, mid-level players, and big players.

Pharmaceutical companies use deal activity to enhance their research activities, regulatory approach, geographic presence, commercialization, and sales. The increasing development of biologics, especially in oncology, has given a significant boost to activity in recent years. Analysis suggests that while the number of deals in 2015 (until July) was lower than the number of deals in 2014, deal value in 2015 has already exceeded that of 2014. Looking at the entire period, although strategic deals were more numerous, M&A deals had the highest deal value. Partnerships were the most preferred type of deal activity, but saw the lowest deal value. North America led in terms of region, followed by Europe and Asia-Pacific. Key deals covered in this report include the acquisition of Allergen by Actavis, asset transactions between Novartis and GlaxoSmithKline, and the partnership between Pfizer and Merck.

Check Complete Report @ http://www.marketintelreports.com/report/GBI062CBR/pharmaceutical-deal-trends-20102015-and-indepth-analysis-of-recent-deal-activity​ 

Scope:

·  Which challenges in the pharmaceutical industry are encouraging deal activity?

·  How important is deal activity to the market?

·  Overview of deal activity from 2010 to 2015 -

·  What are the trends for M&A and strategic deals, and what are the key differences between the sectors?

·  What was the trend for regional involvement in each year?

·  How do variations in terms of therapy area preference affect deal activity?

·  Detailed analysis of recent deal activity -

·  How do announced and completed deals vary?

·  How do deals in 2014 and 2015 compare in terms of quarterly volume and value?

·  Which regions or therapy areas have encouraged recent deal activity?

·  Who are the key players?

·  Complete analysis of recent M&A deals -

·  How do M&A deal types differ in terms of number and value?

·  Which regions and therapy areas have been involved in M&A deals since 2013?

·  Who are the most important players in M&A deals?

·  What was the rationale behind key M&A deals?

·  Complete analysis of recent strategic alliances -

·  What are the different strategic alliance deal types?

·  Which key regions and therapy areas have been involved in strategic alliances since 2013?

·  Which important molecule types and routes of administration have recently been involved in strategic alliances?

·  Who are the key players in strategic alliance deals?

·  What was the rationale behind key strategic alliance deals? 

Download Sample Brochure @ http://www.marketintelreports.com/pdfdownload.php?id=gbi062cbr​ 

Key Reasons to Purchase

This report will allow you to -

·  Gain an insight into pharmaceutical deal activity via in-depth analysis of the current pharmaceutical industry, along with a focus on the most lucrative regions and therapy areas for both M&A and strategic deals

·  Examine detailed analysis of key players, covering companies involved in M&A and strategic alliance deals, important deal activity for all deal types, and deals involving companies with the most numerous and highest-value deals.

·  Understand how the current deals market is changing, using analysis of deals by molecule type, route of administration, and stage of development.

·  Determine the most appropriate deal activity for overcoming challenges and enhancing performance, including detailed analysis of the rationale behind key recent deals.

Order a copy of Pharmaceutical Deal Trends and In-Depth Analysis of Recent Deal Activity Market Report @ http://www.marketintelreports.com/purchase.php?id=gbi062cbr​ 

About us: 

MarketIntelReports (MIR) aim to empower our clients to successfully manage and outperform in their business decisions, we do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.

A group of industry veterans who are well experienced in reputed international consulting firms after identifying the sourcing needs of MNCs for market intelligence, have together started this business savior MarketIntelReports.

MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.

MarketIntelReports currently has more than 10,000 plus titles and 35+ publishers on our platform and growing consistently to fill the “Global Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.​ 

Contact Us:
Sales Manager​
Mayur.S
2711 Centerville Road, Suite 400,
Wilmington,
Delaware,
19808,
United States
http://www.marketintelreports.com
Telephone 1 : 1-302-684-6088